ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SCLP Scancell Holdings Plc

9.30
0.00 (0.00%)
04 Feb 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.30 9.00 10.50 - 0.00 07:31:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -5.86M -0.0057 -16.49 96.42M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.30p. Over the last year, Scancell shares have traded in a share price range of 8.86p to 19.50p.

Scancell currently has 1,036,781,403 shares in issue. The market capitalisation of Scancell is £96.42 million. Scancell has a price to earnings ratio (PE ratio) of -16.49.

Scancell Share Discussion Threads

Showing 62376 to 62394 of 75500 messages
Chat Pages: Latest  2504  2503  2502  2501  2500  2499  2498  2497  2496  2495  2494  2493  Older
DateSubjectAuthorDiscuss
03/8/2023
11:10
Yep, spot on ivy...inane is the epitome of idiocy !
He should stick to tarmac that he "may" know something about.
He's utterly lost in the stock market just like the happy clappers.
Yes, Elliott waves can be daunting initially, all us disciples have been there.
But persevere. All traded markets move in sentiment waves at all degrees of trend.
They are there...there are NO exceptions.
And the question becomes....what's the alternative ?
That's what inane and the clappers do.,.mix up the company with the stock ticker....and call it wrong TIME after TIME.
Because even when the stock rises it does so in sentiment waves. At least 60% of every large rise will periodically be lost. That's how the market moves. So you may as well be able to spot it ...in advance.

2tyke
03/8/2023
11:07
mind you ivy ... admin time for car park ... per month 15 mins to issue invoices

profit ... £3000/m

i hate this job

inanaco
03/8/2023
11:05
or a veterinary salesman pretending to be an executive ... LOL
inanaco
03/8/2023
11:03
But HE is recognised as the top scientist in HIS 'FIELD'.
the real lozan
03/8/2023
10:52
Morning Ruck,
What is he on about what we do know is anyone who sold whether Bermuda/Wiggy/C7 then if they bought back in today they would likely make a big profit.
It does not matter what a Bermuda or anyone else does as the biggest hypocrite is a car park attendant pretending to be a Scientist.

ivyspivey
03/8/2023
10:14
oh ... I don;t recall Bermuda ever declaring his Job or holding on bb;s ..

Privately by email i know what his job was .. and i have never posted that ...

so how on earth do you know ... Ruck ... are you lying again ?

inanaco
03/8/2023
10:10
I bought Ivy;s at 8pNo you didn't. You don't know how many Bermuda sold - the number was probably beyond your finances. You possibly bought some from happy clappers who panicked.
ruckrover
03/8/2023
10:07
Inan,Bermuda hasn't sold. He reduced his holding to a level he is more comfortable with thereby reducing his risk.The two "clowns" on VOX got it right:"Scancell is not a share for buying and holding"
ruckrover
03/8/2023
10:07
we do need some more punters .. but at least they can now see the results

"regression"

Modi1 works

and Ruck you are an complete and utter idiot

fall into the camp that ........ its always somebody's fault but your own

inanaco
03/8/2023
10:05
I bought Ivy;s at 8p
inanaco
03/8/2023
10:04
Bermuda sold ... LOL
inanaco
03/8/2023
09:50
I'm still undecided about the value of Elliot waves.What I do know from observation and experience is that whenever Inan repeats his preposterous predictions, the share price tanks. Inan, £8 is YOUR fantasy, please don't try an suck any more hapless punters into it.
ruckrover
03/8/2023
07:38
the numbers are staggering ....... if we hit the sweet spot
inanaco
03/8/2023
07:36
and of course Merck does not have a clue on values eh Loz !! whats 1.5 billion dollars per year ... in lost sales !!!!

and you certainly don't, stick with your wood drying hobby

inanaco
03/8/2023
07:33
How effective is KEYTRUDA for head and neck cancer?

Keytruda Precision Cancer Immunotherapy Treatment for Head ...
The trial evaluated the effectiveness of Keytruda in the treatment of 192 patients with metastatic or recurrent HNSCC. Anti-cancer responses were achieved in 18% of patients. 85% of anti-cancer responses lasted for at least 6 months, and 71% of anti-cancer responses lasted for at least one year.3 Aug 2022

your problem Loz is you don;t look at the market ....

what is the effect of those numbers above ... well i will tell you ..$1.5 billion from one indication so what is it worth if you can make it work ?

Merck & Co. has failed in an attempt to repeat Keytruda’s metastatic head and neck cancer success in locally advanced disease. But experts still see reasons to keep their hopes up for the drug in early stages of this tumor type.

Adding Keytruda to standard chemoradiation therapy showed a positive trend toward delaying disease worsening in locally advanced head and neck squamous cell carcinoma. But the combination only pared down the risk of disease progression or death by 17% over chemoradiation alone, failing to cross the statistical significance threshold.

In patients whose tumors expressed PD-L1, the Keytruda combo performed better, with a 20% reduction in the risk of progression or death over chemoradiation alone. Those with PD-L1-negative tumors experienced no obvious difference between the two treatment arms. The results, from the Keynote-412 trial, are presented at the ongoing European Society for Medical Oncology congress 2022.

Because of the failure, SVB Securities analyst Daina Graybosch, Ph.D., has removed $1.5 billion from Keytruda’s peak sales estimate. But not all is lost.

inanaco
03/8/2023
07:04
GUFFAW -
"£8 is still on the cards .."
Yeah right Napoleon
Now take YOUR tablets ...

the real lozan
03/8/2023
06:02
If over the next few months we start seeing spectacular results using Checkpoints with synergy it all changes

Scancell will have saved the checkpoint in indications that it has failed in, and patients that have also failed it as a mono or in combo with non immunotherapy agents like chemo hence they are on our trial

we are treating "failed standard of care" except for the adjuvant arms (surgical removal after 6 weeks)

and how many checkpoints are there ?

and how many Moditopes ?

why are checkpoints so valuable

one drug can be used for multiple cancers

whats moditope ?

ATB

inanaco
02/8/2023
20:54
But he might miss a wave mate.
dominiccummings
02/8/2023
14:40
So, let me see. All those expert and professional investment managers, all the wealthy managed funds, all the private investors that continue to get wealthier are either working on waves or consulting 2ticks?

But they waste their time on company information, balance sheets, board appointments and management records. They just don't know their business then do they?

dominiccummings
Chat Pages: Latest  2504  2503  2502  2501  2500  2499  2498  2497  2496  2495  2494  2493  Older

Your Recent History

Delayed Upgrade Clock